Method for the production of Ad26 adenoviral vectors

Details for Australian Patent Application No. 2011214262 (hide)

Owner Crucell Holland B.V.

Inventors Luitjens, Alfred; Van Herk, Herman

Agent Davies Collison Cave

Pub. Number AU-A-2011214262

PCT Pub. Number WO2011/098592

Priority 61/304,553 15.02.10 US; 10153581.3 15.02.10 EP

Filing date 14 February 2011

Wipo publication date 18 August 2011

International Classifications

C12N 7/00 Viruses, e.g. bacteriophages

C12M 3/06 Tissue, human, animal or plant cell, or virus culture apparatus - with filtration, ultrafiltration, inverse osmosis or dialysis means

C12N 15/861 Mutation or genetic engineering - Adenoviral vectors

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/098592 Priority application(s): WO2011/098592

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011214268-Process for manufacturing succinic acid

2011214254-Dual activity kinase domains and uses thereof